Abbott India Limited vs Coal India Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Coal India Limited (Coal mining) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Coal India Limited leads on Revenue (approx.) and Net profit (approx.).
Coal India Limited leads on Revenue (approx.) and Net profit (approx.).
Choose Abbott India if you prefer exposure to branded pharmaceuticals, recognized chronic and specialty therapy brands, and an established doctor and pharmacy distribution network, while accepting concentration in the Indian market and select therapies. Choose Coal India if you need exposure to a dominant domestic coal producer with strategic importance to India’s power sector, large reserves, infrastructure, and government support, while accepting coal-sector, approval, and legacy cost risks. The right choice depends on whether the buyer prioritizes branded healthcare growth or coal-linked infrastructure and energy exposure.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | Coal India Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately INR 1.4 trillion to INR 1.6 trillion, unverified range | AI estimate |
| Net profit (approx.) | INR 1,100-1,300 crore | Approximately INR 350 billion to INR 400 billion, unverified range | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Coal India Limited
Coal mining · India
Coal India Limited is a state-owned coal mining company and a major supplier of coal to India’s power, steel, cement, and industrial sectors. It operates through multiple mining subsidiaries across major coal-bearing regions of India.
Verified financials
No source-verified financials available.
Strengths
- Dominant domestic coal production base
- Strategic importance to India’s power sector
- Large reserve access and established mining infrastructure
- Government ownership and policy support
Weaknesses
- High exposure to coal-dependent power generation
- Operational challenges from land acquisition and environmental approvals
- Labor-intensive legacy cost structure
- Limited international diversification
Opportunities
- Rising near-term domestic energy demand
- Mine modernization and productivity improvements
- Expansion into coal gasification and value-added coal products
- Diversification into renewables and critical minerals
Threats
- Long-term energy transition away from coal
- Environmental regulation and climate-policy pressure
- Competition from private commercial mining
- Logistics bottlenecks and railway capacity constraints
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Coal India Limited: which company leads overall?
Coal India Limited leads on Revenue (approx.) and Net profit (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Protein Industry Outlook — Intelligence Report
India Pharmaceutical Sector — Intelligence Report
Global Radiopharmaceuticals and Theranostics Market — Intelligence Report
India EV Charging Market — Entry Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Coal India Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is a listed Indian pharmaceutical subsidiary of Abbott Laboratories operating in branded prescription and over-the-counter healthcare products.
- Abbott India Limited covers therapeutic areas including gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
- Coal India Limited is a state-owned coal mining company supplying coal to India's power, steel, cement, and industrial sectors.
- Notable: The two companies operate in very different Indian industries, with Abbott India in pharmaceuticals and Coal India in coal mining.